Evaluation of the Efficacy of Distal Gastrectomy for the Treatment of Gastric Cancer (a Case Series)

Gastric Cancer Clinical Trial

Official title:

Evaluation of the Efficacy of Distal Gastrectomy for the Treatment of Gastric Cancer (a Case Series)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05068635
• Other study ID #: SK2021
• Status: Completed
• Start date: January 1, 2013
• Est. completion date: August 31, 2021

Study information

• Verified date: September 2021
• Source: Centre Hospitalier Universitaire Ibn Rochd
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Case series of a retrospective study of patients operated for distal adenocarcinoma of the stomach, either by total gastrectomy or distal gastrectomy at Ibn Rochd University Hospital in Casablanca, with the analysis of outcome of patients on a follow up periode of three years and eight months.

Description:

Thirty (30) patients were treated for gastric cancer and were included in this study. The average age was 64 years, the sex ratio 1.5. Twenty eight patients underwent a distal gastrectomy and 2 patients underwent total gastrectomy. The median number of lymph nodes resected was 6 following distal gastrectomy versus 26 after total gastrectomy. Resection margins were clean except for three patients who underwent a distal gastrectomy. Postoperative complicationsoccured in 05 patients. They were mainly infectious, anastomotic leakage. Two 2 cases of postoperative mortality (<30 days) among patients with distal gastrectomy was noted. A progression to metastasis was found in 3 patients with subtotal gastrectomy, two of whom had insufficient lymph node clearance, compared to no cases of metastasis in patients with total gastrectomy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: August 31, 2021
• Est. primary completion date: December 31, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 15 Years and older

Eligibility

Inclusion Criteria: Patients bwith gastric cancer with histologic confirmation

Exclusion Criteria: Incomplete patients records

Related Conditions & MeSH terms

• Gastric Cancer
• Stomach Neoplasms

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Sylvestre KABURA

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of patients who died for gastric cancer after distal gastrectomy	Mortality rate for patients who underwent distal gastrectomy for gastric cancer	Fourty four months
Primary	Number of patients who developped morbidity after subgastrectmy for gastric cancer	Mortality rate for patients who underwent distal gastrectomy for gastric cancer	Forty for months